Marksans Pharma

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue262.68339.99334.38306.00321.74
Expenses220.38263.65259.65256.09258.17
EBITDA49.4283.6382.4558.3972.07
EBIT42.5876.6275.0250.2163.87
Profit Before Tax42.3076.3374.7249.9063.58
Net Profit32.0263.2055.4637.5948.06
Financial Ratios
Operating Profit Margin19.42%27.10%26.44%19.50%22.54%
Net Profit Margin12.58%20.48%17.78%12.56%15.03%
Earning Per Share (Diluted)0.711.391.220.831.06
Dividends Per Share0.000.000.000.000.00